There are 304 resources available
49O - Clinical Experience of Tabelecleucel in Epstein-Barr Virus-Positive Post-transplant Lymphoproliferative Disease (EBV+ PTLD) Involving the Central Nervous System
Presenter: John Patton
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Collaborative session ESMO-SITC
Resources:
Webcast
Deep immunophenotyping to identify biomarkers and therapeutic targets in solid tumors
Presenter: Thomas Marron
Session: Collaborative session ESMO-SITC
Resources:
Slides
Webcast
Invited Discussant 48O and 49O
Presenter: George Coukos
Session: Proffered Paper session 2
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Collaborative session ESMO-SITC
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2
Resources:
Webcast
Panel discussion: Biological stratification of patients for better immunotherapy
Presenter: All Speakers
Session: Collaborative session ESMO-SITC
Resources:
Webcast
Welcome and introduction
Presenter: Alessandra Curioni-Fontecedro
Session: ESMO Colloquium supported by Novocure: Therapeutic applications and synergies of electric fields in oncology
Resources:
Webcast
Clinical evidence for efficacy &safety of electric fields as monotherapy and in combination with other targeted and immunomodulatory therapies in solid tumours
Presenter: Alessandra Curioni-Fontecedro
Session: ESMO Colloquium supported by Novocure: Therapeutic applications and synergies of electric fields in oncology
Resources:
Slides
Webcast
Research insights in future developments of electric field applications in oncology and potential for combination with IO approaches
Presenter: Teresa Macarulla Mercade
Session: ESMO Colloquium supported by Novocure: Therapeutic applications and synergies of electric fields in oncology
Resources:
Slides
Webcast